National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 15 8 2019
pubmed: 15 8 2019
medline: 17 7 2020
Statut: ppublish

Résumé

BackgroundAs a part of the national strategy on the prevention of healthcare-associated infections (HAI), a point prevalence survey (PPS) was conducted in acute care hospitals in Switzerland.AimOur objective was to assess the burden of HAI in Swiss acute care hospitals.MethodsAll acute care hospitals were invited to participate in this cross-sectional survey during the second quarter of 2017. The protocol by the European Centre for Disease Prevention and Control was applied. Patients of all ages, hospitalised on the day of survey were included, except when admitted to outpatient clinics, emergency and psychiatry.ResultsNinety-six acute care hospitals (79% of all hospitals ≥ 100 beds) provided data on 12,931 patients. Pooled and randomised HAI prevalences were 5.9% (95% confidence interval (CI): 5.5-6.3) and 5.4% (95% CI: 4.8-6.0), respectively. The HAI incidence was estimated at 4.5 (95% CI: 4.0-5.0). The most common type of HAI was surgical site infection (29.0%), followed by lower respiratory tract (18.2%), urinary tract (14.9%) and bloodstream (12.8%) infections. The highest prevalence was identified in intensive care (20.6%), in large hospitals > 650 beds (7.8%), among elderly patients (7.4%), male patients (7.2%) and patients with an ultimately (9.3%) or rapidly (10.6%) fatal McCabe score.DiscussionThis is the first national PPS of Switzerland allowing direct comparison with other European countries. The HAI prevalence was at European Union average (5.9% in 2016 and 2017), but higher than in some countries neighbouring Switzerland. Based on the limited information from previous surveys, HAI appear not to decrease.

Identifiants

pubmed: 31411135
doi: 10.2807/1560-7917.ES.2019.24.32.1800603
pmc: PMC6693290
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Infect Control Hosp Epidemiol. 2005 Nov;26(11):891-4
pubmed: 16320985
J Hosp Infect. 2007 Jun;65 Suppl 2:115-23
pubmed: 17540254
N Engl J Med. 2014 Mar 27;370(13):1198-208
pubmed: 24670166
PLoS One. 2014 Apr 08;9(4):e93898
pubmed: 24714418
Infect Control Hosp Epidemiol. 2014 Jun;35(6):674-84
pubmed: 24799644
J Hosp Infect. 2014 Sep;88(1):40-7
pubmed: 25063012
Lancet Infect Dis. 2015 Feb;15(2):212-24
pubmed: 25467650
Lancet Infect Dis. 2016 Jun;16(6):724-734
pubmed: 26907734
PLoS Med. 2016 Oct 18;13(10):e1002150
pubmed: 27755545
Lancet Infect Dis. 2016 Dec;16(12):e288-e303
pubmed: 27816414
Lancet Infect Dis. 2017 Apr;17(4):381-389
pubmed: 28089444
Dtsch Arztebl Int. 2017 Dec 15;114(50):851-857
pubmed: 29271343
Lancet Infect Dis. 2018 Mar;18(3):252
pubmed: 29485090
Crit Care Med. 2018 Jul;46(7):1167-1174
pubmed: 29629985
Ann Epidemiol. 2018 Jul;28(7):475-480.e1
pubmed: 29661679
Swiss Med Wkly. 2018 Apr 26;148:w14617
pubmed: 29698542
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Am J Epidemiol. 1985 Feb;121(2):182-205
pubmed: 4014115
Am J Epidemiol. 1981 Jan;113(1):1-11
pubmed: 7457475

Auteurs

Walter Zingg (W)

Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
These authors contributed equally.

Aliki Metsini (A)

Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
These authors contributed equally.

Carlo Balmelli (C)

Infection Control Programme, Cantonal Hospital Authority, Ticino, Switzerland.

Dionysios Neofytos (D)

Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.

Michael Behnke (M)

Institute of Hygiene and Environmental Medicine, Charité University Medicine Berlin, Berlin, Germany.

Céline Gardiol (C)

Swiss Federal Office of Public Health, Bern, Switzerland.

Andreas Widmer (A)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland.

Didier Pittet (D)

Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Members of the Swissnoso Network are acknowledged at the end of this article.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH